Startups

EarliTec Diagnostics Secures $21.5M Series B Funding to Advance Autism Diagnosis

EarliTec Diagnostics Secures $21.5M Series B Funding to Advance Autism Diagnosis

EarliTec Diagnostics Secures $21.5M Series B Funding to Advance Autism Diagnosis and Treatment EarliTec Diagnostics, a Decatur, Georgia-based medical device company, has recently secured a significant investment of $21.5 million in Series B funding, with contributions from Nexus NeuroTech Ventures and Venture Investors Health Fund. This capital infusion is intended to bolster the company’s commercialization […]

EarliTec Diagnostics Secures $21.5M Series B Funding to Advance Autism Diagnosis Read More »

Juniper Biomedical Secures Funding to Revolutionize Pelvic Health Care

Juniper Biomedical Secures Funding to Revolutionize Pelvic Health Care

Juniper Biomedical Secures Funding to Revolutionize Pelvic Health Solutions Juniper Biomedical, a medical device company specializing in pelvic health disorders treatment, has successfully completed an oversubscribed $2 million Series Seed financing round. Additionally, the company has been awarded $1 million through the NIH Common Fund as a winner of the NIH SPARC Neuromod Prize. This

Juniper Biomedical Secures Funding to Revolutionize Pelvic Health Care Read More »

Eric Schmidt awards $14 million for brain nanotechnology

This Former Google CEO Funds $14 Million for Forest Neurotech.

Forest Neurotech’s groundbreaking ultrasound-based brain-computer interface (BCI) technology represents a paradigm shift in neurology. Unlike traditional BCIs that rely on invasive procedures, Forest’s approach offers a minimally invasive solution that can sense and modulate the entire brain without penetration. This innovative technology opens up a world of possibilities for diagnosing, monitoring, and treating neurological conditions with unprecedented precision and effectiveness. With the support of visionary leaders like Eric Schmidt and Convergent Research, Forest Neurotech is poised to revolutionize the field of neurotechnology, paving the way for a brighter future for individuals with neurological injuries or diseases.

This Former Google CEO Funds $14 Million for Forest Neurotech. Read More »

SOOMA SECURES €5M FUNDING FOR AT-HOME BRAIN STIMULATION FOR DEPRESSION

This Company Raises €5M for Depression Treatment

In the ever-evolving landscape of mental health treatment, Sooma Medical emerges as a beacon of innovation and hope. With its pioneering approach to depression treatment using Transcranial Direct Current Stimulation (tDCS), Sooma is reshaping the way we perceive and address mental health challenges. Through a combination of cutting-edge technology, clinical expertise, and a relentless commitment to patient care, Sooma is paving the way for a brighter future for individuals battling depression worldwide.

This Company Raises €5M for Depression Treatment Read More »

BrainCheck, a digital health company specializing in cognitive assessments, announced it secured $15 million in funding. The investment was led by seed-stage investor Next Coast Ventures, venture capital firm S3 Ventures and UPMC Enterprises.

This cognitive assessment platform raises another $15M.

This cognitive assessment platform raises another $15M. Did you hear the news? BrainCheck, a leading innovator in digital cognitive assessment, has recently secured $15 million in funding. This substantial investment underscores the growing recognition of BrainCheck’s pivotal role in transforming cognitive healthcare. Utilized by hundreds of hospitals and clinical practices, BrainCheck’s platform has become instrumental

This cognitive assessment platform raises another $15M. Read More »

After Three Years of Clinical Studies in Brain Imaging and Happiness Research, Matter Debuts Consumer App in Public Beta

MATTER NEUROSCIENCE: This startup secures $26M in funding to prevent unhappiness.

MATTER NEUROSCIENCE: This startup secures $26M in funding to prevent unhappiness. Amidst escalating concerns of depression, addiction, and anxiety, Matter Neuroscience emerges as a beacon of hope, fortified by a significant $26 million funding injection. Spearheaded by biotech luminary Axel Bouchon, this endeavor represents a pivotal stride in comprehending and nurturing mental well-being. Dedicated to

MATTER NEUROSCIENCE: This startup secures $26M in funding to prevent unhappiness. Read More »

Samphire Neuroscience, a cutting-edge medtech startup, just secured an impressive $2.3 million

Say Goodbye to Period Pain: How This Startup Raised $2.3M to Tackle PMS with Neurotech Wearables!

Say Goodbye to Period pain: How This Startup Raised $2.3M to Tackle PMS with Neurotech Wearable! Exciting news is on the horizon for women’s health! Samphire Neuroscience, a cutting-edge medtech startup, just secured an impressive $2.3 million in pre-seed funding to push forward their groundbreaking neurotechnology wearable, Nettle. This innovative device is set to shake

Say Goodbye to Period Pain: How This Startup Raised $2.3M to Tackle PMS with Neurotech Wearables! Read More »

Elemind raises $12M

All About Elemind: Funding, Technology, and What It Means for You

All About Elemind: Funding, Technology, and What It Means for You Elemind, a neurotechnology startup led by renowned scientists and entrepreneurs, has secured $12 million in funding. Their mission? To revolutionize wellness with a drug-free, personalized approach. Since 2019, the Elemind team has developed its technology in secrecy, securing three critical patents for its core

All About Elemind: Funding, Technology, and What It Means for You Read More »